Ferrari Earnings: Stronger-Than-Expected Personalization Offsets US Tariff and Currency Headwinds

We think Ferrari stock is fairly valued.

A Ferrari logo is displayed on a wheel in the department Ferrari factory in Maranello, Italy.
Marco Vasini via AP

Key Morningstar Metrics for Ferrari

What We Thought of Ferrari’s Earnings

Ferrari RACE‘s revenue growth of 7% (9% at constant currency) was mainly driven by higher personalization, offsetting fewer Daytona deliveries. Volumes grew 0.5%. The EBIT margin was flat despite US tariffs being margin-dilutive, foreign-exchange headwinds, and solid growth in racing and marketing costs.

Why it matters: Top-line growth reflects Ferrari’s ability to drive growth through price and mix, fully offsetting strong cost growth. However, the fourth quarter is expected to be weaker.

  • Ferrari is undergoing a significant model changeover, which will see lower volumes year on year. With the growth in new model launches, higher depreciation and amortization costs are expected. The step change in racing spending will also begin in the fourth quarter.
  • Under the previous 27.5% US import tariff, Ferrari’s commercial policy was to increase the prices of vehicles sold into the US by up to 10%. At the lower 15% tariff, the additional price increase has been reduced to up to 5%. This will limit top-line growth.

The bottom line: We have reduced our fair value estimate marginally to EUR 370 from EUR 380 per share due to higher selling, general, and administrative costs.

  • Management reiterated that the guidance provided at the capital markets day sets a floor for the company’s growth over the next few years. With the upcoming start of sales of the F80 supercar and the Elettrica, its first electric vehicle, which we believe will be priced to reflect the significant step change in innovation and continued outperformance of personalization, we view the company’s pricing/mix guidance as prudent, reflecting shorter-term softer pricing trends in the luxury segment.

Editor's Note: This analysis was originally published as a stock note by Morningstar Equity Research.

The author or authors do not own shares in any securities mentioned in this article. Find out about Morningstar's editorial policies.